Mohamed R Elnagar

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Papillary Thyroid

Top Venues

Plants (Basel, Switzerland)

Drug design, development and therapy

Journal of enzyme inhibition and medicinal chemistry

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A Ewes, Mashooq Ahmad Bhat, Noha I Ziedan, Hamed W El-Shafey, Ahmed A B Mohamed, Mohamed R Elnagar, Abdullah Haikal, Dina I A Othman, Abdullah A Elgazar, Ahmed H A Abusabaa, Kamal S Abdelrahman, Osama M Soltan, Mostafa M Elbadawi
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Abdallah E Abdallah, Reda R Mabrouk, Mohamed R Elnagar, Amel Mostafa Farrag, Mohamed H Kalaba, Mohamed H Sharaf, Esmail M El-Fakharany, Dina Abed Bakhotmah, Eslam B Elkaeed, Maged Mohammed Saleh Al Ward
New Series of VEGFR-2 Inhibitors and Apoptosis Enhancers: Design, Synthesis and Biological Evaluation. Drug design, development and therapy 16 (2022)
Mohamed R Abdelaal, Esraa Ibrahim, Mohamed R Elnagar, Sameh H A Soror, Hesham Haffez
Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach. International journal of molecular sciences 23 (16) (2022)
Hanin S Salam, Mohamed M Tawfik, Mohamed R Elnagar, Hamdoon A Mohammed, Mohamed A Zarka, Nabil Saied Awad
Potential Apoptotic Activities of Hylocereus undatus Peel and Pulp Extracts in MCF-7 and Caco-2 Cancer Cell Lines. Plants (Basel, Switzerland) 11 (17) (2022)
Mohamed R Abdelaal, Sameh H A Soror, Mohamed R Elnagar, Hesham Haffez
Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy. Molecules (Basel, Switzerland) 26 (2) (2021)